Previous close | 4.6000 |
Open | 5.0000 |
Bid | 4.1000 |
Ask | 7.6000 |
Strike | 80.00 |
Expiry date | 2024-08-16 |
Day's range | 4.6000 - 5.0000 |
Contract range | N/A |
Volume | |
Open interest | 169 |
Roche (RHHBY) gets exclusive, target-specific rights to Ascidian's RNA exon editing technology for undisclosed neurological targets for an initial payment of $42 million.
Terns Pharmaceuticals, Inc. (TERN) outperforms the industry year to date on encouraging pipeline progress of its oncology candidate.
Ligand Pharmaceuticals Incorporated ( NASDAQ:LGND ) shareholders should be happy to see the share price up 10% in the...